[1]
Nitika Hans, “Determining the Efficacy and Safety of Teneligliptin and Metformin Versus Glimepiride and Metformin in Patients of Type-2 Diabetes Mellitus Uncontrolled with Monotherapy”, TIPR-V10, pp. 46–63, Aug. 2021.